Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00771355 · ClinicalTrials.gov registry record
In Vivo Imaging of Pigmentary Disorders by Reflectance Confocal Microscopy
A clinical trial, sponsored by Massachusetts General Hospital.
- Terminated
- Registry status
- 40
- Enrollment target
NCT00771355: Clinical Trial study, sponsored by Massachusetts General Hospital.
NCT00771355 is a clinical trial that was terminated before completion, run by Massachusetts General Hospital. The registered enrollment target is 40 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00771355 was terminated before completion, sponsored by Massachusetts General Hospital.
- TERMINATED
- Registry status
- 40 participants
- Enrollment target
Study Summary
This is a pilot study to evaluate the findings of the Reflectance Confocal Microscopy when performed in cutaneous pigmentary disorders, such as vitiligo, melasma, post-inflammatory hyper-pigmentation and hypo-pigmentation. Confocal Microscopy is a recent diagnostic technique that has been used for observation of skin conditions that affect the superficial layers of the skin.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2008-08 |
| Est. Completion | 2010-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00771355
The ClinicalTrials.gov registry entry for NCT00771355 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00771355 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00771355 about?
NCT00771355 is a clinical study titled "In Vivo Imaging of Pigmentary Disorders by Reflectance Confocal Microscopy". This is a pilot study to evaluate the findings of the Reflectance Confocal Microscopy when performed in cutaneous pigmentary disorders, such as vitiligo, melasma, post-inflammatory hyper-pigmentation and hypo-pigmentation. Confocal Microscopy is a recent diagnostic technique that has been used for o...
What is the current status of trial NCT00771355?
This trial is currently terminated. The enrollment target is 40 participants. The study started on 2008-08. Estimated completion is 2010-07.
Who is sponsoring clinical trial NCT00771355?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.